Cite
HARVARD Citation
Noel, M. et al. (2022). A randomized phase II study of SM‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond. Cancer medicine. pp. 4169-4181. [Online].